Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Heart ; 95(9): 715-20, 2009 May.
Article in English | MEDLINE | ID: mdl-19036758

ABSTRACT

AIMS: A nested case-control study of 75 patients with cardiac device infections (CDI) and 75 matched controls was conducted to evaluate time course, risk factors, culture results and frequency of CDI. METHODS AND RESULTS: CDI occurred in 75/3410 (2.2%) device implantation and revision procedures, performed between 2000 and 2007. The time delay between device procedure and infection ranged from 0 to 64 months (mean 14 (SD 16)), 21 patients (28%) had an early infection (<1 month), 26 (35%) a late infection (1-12 months) and 28 (37%) a delayed infection (>12 months). Of interest, 18 (24%) patients presented with an infection >24 months after the device-related procedure. Time delay until infection was significantly shorter when cultures were positive for micro-organisms compared to negative cultures (8 (12) vs 18 (18) months, p = 0.03). Pocket cultures in delayed infections remained more often negative (61% vs 23%, p = 0.01). Independent CDI risk factors were: device revision (odds ratio (OR) 3.67; 95% confidence interval (CI), 1.51 to 8.96), renal dysfunction defined as glomerular filtration rate <60 ml/min (OR 4.64; CI, 1.48 to 14.62) and oral anticoagulation use (OR 2.83; CI 1.20 to 6.68). CONCLUSION: CDI occurred in 2.2% of device procedures, with 24% occurring more than two years after the device-related procedure. Renal dysfunction, device revisions and oral anticoagulation are potent risk factors for CDI.


Subject(s)
Defibrillators, Implantable/adverse effects , Prosthesis-Related Infections/etiology , Staphylococcal Infections/complications , Aged , Case-Control Studies , Cross Infection/prevention & control , Defibrillators, Implantable/microbiology , Device Removal , Female , Humans , Male , Middle Aged , Odds Ratio , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/epidemiology , Renal Insufficiency/complications , Risk Assessment , Staphylococcal Infections/diagnosis , Staphylococcal Infections/mortality , Time Factors , Treatment Outcome
2.
Biol Neonate ; 78(2): 98-105, 2000.
Article in English | MEDLINE | ID: mdl-10971002

ABSTRACT

The aim of the present study was to investigate the effect of immediate post-hypoxic-ischemic (HI) inhibition of nitric oxide synthesis by N(omega)-nitro-L-arginine (NLA) on cardiac function and reactive oxygen species production. Fifteen newborn lambs were subjected to severe HI. Upon resuscitation 5 received 10 mg NLA/kg, 4 40 mg NLA/kg and 6 a placebo. Left ventricular (LV) contractility, cardiac output (CO), non-protein-bound iron (NPBI), ratio of reduced/oxidized ascorbic acid, alpha-tocopherol, sulfhydryl groups and malondialdehyde were measured before and 15, 60 and 120 min after resuscitation. There was a significant decrease in CO in all 3 groups at 60 min post-HI (p < 0.05). Reactive oxygen species production was also highest at 60 min post-HI (significantly increased NPBI and decrease in sulfhydryl groups in control lambs; p < 0.05). These results suggest neither a positive nor a negative effect of nitric oxide synthesis inhibition on post-HI myocardial performance but may suggest a positive effect of NLA on reactive oxygen species-mediated post-HI damage.


Subject(s)
Animals, Newborn/physiology , Enzyme Inhibitors/pharmacology , Heart/physiopathology , Hypoxia-Ischemia, Brain/physiopathology , Nitric Oxide Synthase/antagonists & inhibitors , Animals , Cardiac Output , Enzyme Inhibitors/therapeutic use , Heart Ventricles/physiopathology , Hypoxia-Ischemia, Brain/drug therapy , Myocardial Contraction , Nitroarginine/pharmacology , Nitroarginine/therapeutic use , Reactive Oxygen Species/metabolism , Sheep , Venae Cavae
SELECTION OF CITATIONS
SEARCH DETAIL
...